American Society Of Clinical Oncology

A review of oncology trials showed approximately two-thirds did not report results on any of three key platforms within 1 year of completion.

Supervised resistance and aerobic exercise appeared to improve sexual function among men with prostate cancer, according to study results presented at ASCO Breakthrough.

Selinexor maintenance after systemic therapy extended median PFS more than four times longer than placebo for women with advanced or recurrent TP53 wild-type endometrial cancer, according to phase 3 study results.

Tulane University School of Medicine has chosen Nicholas J. Petrelli, MD, FACS, as the recipient of the school’s lifetime achievement award.

ASCO has issued updated guidelines on evaluation and management of vulnerabilities in patients aged 65 years and older prior to initiating systemic cancer treatment.

System-level strategies that reduce unnecessary work and make team members feel valued can improve clinician well-being and ensure a sustainable oncology workforce, according to presenters at a town hall session during ASCO Annual Meeting.

Editor’s note: This is the fourth in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting focused on the human side of oncology.

Editor’s note: This is the third in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting focused on the human side of oncology.

ASCO Chief Medical Officer Julie R. Gralow, MD, FACP, FASCO, urged members of Congress to take action on cancer drug shortages, which she described as the worst she has witnessed during her 30-year career in oncology.

Fears of an oncology workforce shortage have been mounting for more than a decade as both the percentage of oncologists nearing retirement age and number of Americans with a history of cancer increase annually.